This could be a record year for biotech investments

NVCAThe National Venture Capital Association, PricewaterhouseCoopers and Thomson Reuters report that venture capital funds are on a track for a record year of investments in biotech start-ups, perhaps as much as $7 billion. Click here to learn more.

Tom Ballard

By Tom Ballard, Chief Alliance Officer,
Pershing Yoakley & Associates. P.C.

eNews & Updates

Sign up to receive posts via email.

Connect With Us

Upcoming Events

Links to Partners